The increasing number of polymorphic DNA probes specific to the human X chromosome,' and the steadily increasing data on the linkage relationships between them and X linked disease loci,2-5 promise that multiprobe diagnosis will soon become a feasible proposition in many of these disorders. The use of closely linked probes known to lie on either side of the disease locus (bridging probes) would, in multiply informative families, reduce the rate of misdiagnosis to the order of 1% or less in situations where linkage phase is known with certainty. However, combining the results of even loosely linked probes with other predictors of carrier status, for example, creatine kinase levels in Duchenne muscular dystrophy, can produce estimates of risk sufficiently low (or high) to be likely to influence an at risk female's course of action. Unfortunately, except in the simplest cases, the calculation of such combined risks is tedious in the extreme. If other variables are to be incorporated, such as new mutation, the complexity will be such that errors will be almost inevitable. There is, therefore, a need for automation of the calculation process.
One method, using linkage analysis programmes such as LIPED,6 has been described7 but such programmes do not allow the possibility of new mutation or the easy incorporation of other predictors of genotype. In order to perform the calculation allowing for these factors, multiple runs of the programme are necessary, the various likelihoods produced being combined by hand to evaluate the risk. In most situations, this method will be almost as tedious and error prone as hand calculation. A further disadvantage is that information from only two marker loci can be considered by such a Received for publication 7 March 1985. Revised version accepted for publication 3 April 1985. method. In extensive families, it is likely that different markers will be informative (that is, key subjects are heterozygous for the marker) in different parts of the pedigree and that useful information may be neglected if a programme cannot cope with more than two markers.
In this paper, a pair of programmes is presented which allows the speedy calculation of risk of carrier status of X linked diseases, incorporating family structure, linkage data of multiple probes, other predictors of carrier status, predictors of hemizygote status, and the possibility of new mutation.
The programme: 'moll' and 'tarde' There are two programmes used in this package for risk calculation in X linked disorders, called 'moll' and 'tarde'. Only the briefest account of the mechanisms of these programmes will be given here, the emphasis being to demonstrate their use. The programmes are flexible in that they allow the user to define the type of function required. For example, the programme must perform different functions when dealing with diseases with high or negligibly small mutation rates. These different functions are declared by the user by taking various 'options' when running the programmes. Thus, the description of the programmes is essentially a description of the available options. ' 
MOLL'
The first programme of the pair is 'moll', which takes input very similar to that taken by LIPED6 and PEDIG.8 Its function is to assign values to each and every unassigned allele in the input data and to calculate the prior probability of each permutation of the assigned values. The output from 'moll' is the 35 count of recombinant and non-recombinant meiotic events between each pair of loci in a standardised format, given the currently assumed permutation of alleles and the probe/disease ordering. This count is followed by a modified prior probability, which is calculated from population frequencies of alleles, mutation rates (if allowed), and factors of 0n5 (one for each child of a woman who is heterozygous at any locus). In effect, this programme produces an equation of risk which is a function of the various recombination fractions.
It is assumed that the order of the DNA probes along the chromosome is known, but that the position of the disease locus is not. Thus, the significance of the family has to be assessed not only for each possible allele/haplotype permutation, but also for each possible disease/probe ordering. The output of this programme forms the input to the second programme, 'tarde'.
Each of the options available within 'moll' is designated by a single letter. The most important of these will be described here.
r. This option indicates that the output is to be used to calculate the classical genetic risk to a subject, such as would be required in carrier identification. The programme requires the user to define the subject to be counselled and checks each permutation of alleles to see if that subject is a carrier under the current assumption. If she is, the line on output (which describes the current permutation) will be flagged. If not, no flag will be set.
p. This option allows the production of data suitable for the calculation of a probability distribution on risk. It is envisaged that this option would be used where antenatal diagnosis was being undertaken. Under this option, the user must define the fetus and the at risk parent. The p and r options cannot be run simultaneously.
m. This option allows the programme to permit a single new mutation in its description of the family. The user must specify male to child and female to child mutation rates separately. If this option is not taken, the processing of any allele/haplotype assumption which requires a mutation (for example, a normal mother having an affected son) will be abandoned without producing any output. This option can be taken with any of the other options.
1. This option requires the incorporation of another predictor of carrier status, such as creatine kinase (CK) data. The relative likelihood of the predictor value of each female is given in the input data.
h. This option is similar to option 1 in that it incorporates other predictors, but this time for males and females. This might be used when the disease status of hemizygotes can be statistically inferred, as in 'age of onset' calculations for late onset disorders.
a. This option allows the user to change the number of alleles at each locus. The default number of alleles is two.
This programme can cope with families of virtually arbitrary structure. Up to 150 subjects can be specified in the input data, with data on up to five probes. If more probes are informative, it is only necessary to alter a single line of the programme to increase this number. Each probe is allowed to have a maximum of nine alleles, but the disease locus can have only two, the disease gene being defined as allele 2 at the disease locus. Again, alteration of a single line of the programme allows the number of alleles to be increased to 99.
TARDEE
This programme takes the output data from 'moll' and translates it into a risk for the subject. It solves the equation of risk by substituting the-values of the recombination fractions. Three options are currently available.
f. This option specifies that the user is confident of the position of the disease locus and that he is willing to specify values for each recombination fraction and a probe/disease order. Therefore, a single figure of risk is output.
t. Under this option, the user specifies a position for the disease locus, but not recombination fractions. Risks are calculated and presented in tabular form for all sets of probe/disease recombination fractions in 5% increments. Probe-probe recombination fractions are calculated from the probe/ disease fractions. It is not feasible to produce three dimensional tables so this option is restricted to a mnaximum of two probes.
p. This option can be used on data produced by ,moll' under its p option to produce a probability distribution on risk. In the second pedigree (fig 2) , the problem is to provide data for prenatal diagnosis for the proband. Here there are data from two probes and also from a predictor of carrier status. An edited form of the probability distributions of risk for the four possible male fetuses of the proband are shown in table 2. In this the risk is taken to be the proportion of offspring which can be expected to be affected. Where the two probes agree that the fetus is at low risk, such risks will be of the order of 1%, possibly extending up to 5% for useful probes. If they disagree, the risk will be around 50% if the probes have equal recombination fractions or to one side if these are unequal. Thus, the risk will tend to fall into one of the four regions shown in the table. In this calculation, the p, m, and options of 'moll' and the p option of 'tarde' were taken.
The third pedigree (fig 3) is one of the most complex ones which have been tested and the results checked. In this pedigree, information can be obtained from three probes and a predictor of carrier status. The assumed probe/disease order is 
